Wohin will eigentlich Neogen noch?
| eröffnet am: | 01.11.01 21:34 von: | Dr.UdoBroemme |
| neuester Beitrag: | 06.11.01 21:29 von: | Dr.UdoBroemme |
| Anzahl Beiträge: | 17 | |
| Leser gesamt: | 7037 | |
| davon Heute: | 1 | |
bewertet mit 1 Stern |
||
|
|
||
01.11.01 21:34
#1
Dr.UdoBroemme
Wohin will eigentlich Neogen noch?
Obwohl die Bios allgemein eher gegen flat tendieren, steigt NEOG ohne irgendwelche news immer höher...
Gruß Dr. Broemme
Gruß Dr. Broemme
01.11.01 21:47
#2
Reinyboy
Kann ich dir verraten,
Schau mal deren Geschäftsfeld an. Test-Kits, food saftey.
Alles klar ??
Grüße Reinyboy
Alles klar ??
Grüße Reinyboy
01.11.01 21:51
#4
Dr.UdoBroemme
war schon klar :-)
Aber ist es nur die Paranoia? Welche "Gefahren" sollen denn mit den NEOG-Tests ausgeräumt werden? Eigentlich gehts doch mehr um Nachweis von Schadstoffrückständen, Erkennung von Mutterkorn etc. , wenn ich das richtig in Erinnerung habe.
Gruß Dr. Broemme
Gruß Dr. Broemme
01.11.01 22:03
#6
Dr.UdoBroemme
Doch was übersehen...
Die haben ja Firmen zugekauft, die in dem Markt tätig sind. Trotzdem, wenn die Paranoia nachlässt...
Finanziell sind sie zumindest wohl gesund und weiter am expandieren.
Monday September 24, 9:23 am Eastern Time
Press Release
SOURCE: Neogen Corporation
Neogen Reports 20% Increase in Revenues
LANSING, Mich., Sept. 24 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG -
news) announced today that revenues for the first quarter of its 2002 fiscal year, which ended
Aug. 31, were 20% higher than the previous fiscal year's first quarter. Neogen's net income
increased to $0.14 per share, as compared to $0.12 per share a year earlier.
Neogen reported first quarter revenues of $9,732,000, a 20% increase compared to
$8,124,000 in the first three months of fiscal year 2001. The quarter's revenues were the
most for any quarter in the Company's history. Neogen also continued its strong growth in
operating income, increasing 54% on a quarter-to-quarter comparison with the previous fiscal
year.
``We again demonstrated in the first quarter that we can continue to deliver the exceptional
performance investors expect from us even while integrating acquisitions,'' said James
Herbert, Neogen's president. ``Our solid first quarter results are further evidence of the
operational strength throughout Neogen. We are extremely proud of our record of 34 straight
profitable quarters from operations, while growing at an accelerating rate.''
The Company's food pathogen detection products grew at over 23%, and revenues from
Animal Safety equine products increased 34% during the quarter.
The summer of 2001 saw the first deliveries of Neogen's new D3 Needles(TM). The D3
needles combine superior strength with a unique quality that makes them detectable by
processing plant metal detectors. With broken needles a major concern of meat producers,
the D3 Needles represent a significant opportunity for substantial growth in the Animal Safety
market.
In its first quarter, Neogen completed the acquisitions of two food safety companies,
Gene-Trak® Systems of Hopkinton, Mass., and QA Life Sciences of San Diego, Calif.
Gene-Trak's DNA probe technology products offer a complementary approach to Neogen's
immunosorbent assay technology for the testing of food for dangerous bacteria. Gene-Trak's
recently introduced automated testing system, which allows for the rapid and extremely
accurate simultaneous processing of a large number of samples, provides Neogen with a
uniquely valuable tool to offer the food industry. Gene-Trak's revenues were approximately
$3 million in its most recently completed fiscal year.
Acquiring QA Life Sciences allows Neogen to offer the food safety market the ISO-GRID(TM) filter membrane system to
detect foodborne pathogens. The system offers some distinct competitive advantages, especially in testing for yeast and molds.
QA's sales were less than $1 million in its last fiscal year.
``Integration of these acquisitions will be important to our future growth as the integration of past acquisitions has been,'' said
Lon Bohannon, Neogen's chief operating officer. ``Our outstanding first quarter results show that we can bring in new
acquisitions and maintain organic growth, while at the same time control manufacturing costs, and sales, general and
administrative expenses.''
Neogen Corporation develops and markets products and services dedicated to food and animal safety. The Company's Food
Safety Division markets diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens,
drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics,
veterinary instruments, veterinary pharmaceuticals and nutritional supplements.
Finanziell sind sie zumindest wohl gesund und weiter am expandieren.
Monday September 24, 9:23 am Eastern Time
Press Release
SOURCE: Neogen Corporation
Neogen Reports 20% Increase in Revenues
LANSING, Mich., Sept. 24 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG -
news) announced today that revenues for the first quarter of its 2002 fiscal year, which ended
Aug. 31, were 20% higher than the previous fiscal year's first quarter. Neogen's net income
increased to $0.14 per share, as compared to $0.12 per share a year earlier.
Neogen reported first quarter revenues of $9,732,000, a 20% increase compared to
$8,124,000 in the first three months of fiscal year 2001. The quarter's revenues were the
most for any quarter in the Company's history. Neogen also continued its strong growth in
operating income, increasing 54% on a quarter-to-quarter comparison with the previous fiscal
year.
``We again demonstrated in the first quarter that we can continue to deliver the exceptional
performance investors expect from us even while integrating acquisitions,'' said James
Herbert, Neogen's president. ``Our solid first quarter results are further evidence of the
operational strength throughout Neogen. We are extremely proud of our record of 34 straight
profitable quarters from operations, while growing at an accelerating rate.''
The Company's food pathogen detection products grew at over 23%, and revenues from
Animal Safety equine products increased 34% during the quarter.
The summer of 2001 saw the first deliveries of Neogen's new D3 Needles(TM). The D3
needles combine superior strength with a unique quality that makes them detectable by
processing plant metal detectors. With broken needles a major concern of meat producers,
the D3 Needles represent a significant opportunity for substantial growth in the Animal Safety
market.
In its first quarter, Neogen completed the acquisitions of two food safety companies,
Gene-Trak® Systems of Hopkinton, Mass., and QA Life Sciences of San Diego, Calif.
Gene-Trak's DNA probe technology products offer a complementary approach to Neogen's
immunosorbent assay technology for the testing of food for dangerous bacteria. Gene-Trak's
recently introduced automated testing system, which allows for the rapid and extremely
accurate simultaneous processing of a large number of samples, provides Neogen with a
uniquely valuable tool to offer the food industry. Gene-Trak's revenues were approximately
$3 million in its most recently completed fiscal year.
Acquiring QA Life Sciences allows Neogen to offer the food safety market the ISO-GRID(TM) filter membrane system to
detect foodborne pathogens. The system offers some distinct competitive advantages, especially in testing for yeast and molds.
QA's sales were less than $1 million in its last fiscal year.
``Integration of these acquisitions will be important to our future growth as the integration of past acquisitions has been,'' said
Lon Bohannon, Neogen's chief operating officer. ``Our outstanding first quarter results show that we can bring in new
acquisitions and maintain organic growth, while at the same time control manufacturing costs, and sales, general and
administrative expenses.''
Neogen Corporation develops and markets products and services dedicated to food and animal safety. The Company's Food
Safety Division markets diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens,
drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics,
veterinary instruments, veterinary pharmaceuticals and nutritional supplements.
01.11.01 22:44
#8
Dr.UdoBroemme
@flexo
Habe NEOG schon über ein Jahr auf der Watchlist, aber immer den richtigen Einstiegspunkt verpasst :-(
Gruß Dr. Broemme
Gruß Dr. Broemme
01.11.01 22:51
#9
flexo
Würdest du mir bitte deine Watchlist zur Verfügung
stellen? Gern unkommentiert, per eMail - würde ich gerne einfach mal durchsehen?!
01.11.01 22:55
#10
Dr.UdoBroemme
Da sind keine großen Überraschungen dabei.
Meine "richtige" mit ca. 70 Werten ist beim Exodus von dem Finnenbroker im Nirvana verschwunden.
Aber ich kann Dir mein Login für Yahoo gerne schicken, wenn Du mir versprichst, nicht darin rumzupfuschen :-))
Gruß Dr. Broemme
Aber ich kann Dir mein Login für Yahoo gerne schicken, wenn Du mir versprichst, nicht darin rumzupfuschen :-))
Gruß Dr. Broemme
01.11.01 23:00
#11
flexo
Hähä
natürlich werde ich alles durcheinandersauen! Es dankt für das entgegengebrachte Vertrauen:
f.
f.
01.11.01 23:14
#13
flexo
Danke!
Was werde ich beim ersten Anblick sagen: Uhhhhhhh, Ahhhhhhhh oder: Du meine Güte...
01.11.01 23:28
#14
Dr.UdoBroemme
Viele interessante Werte findet man z.B. hier
http://www.redchip.com/
Alles Smallcaps oder auf Deutsch "Nebenwerte". Hier habe ich schon viele gute Sachen entdeckt und deren Performance mit den Portfoliowerten lässt sich auch sehen.
Gruß Dr. Broemme
Alles Smallcaps oder auf Deutsch "Nebenwerte". Hier habe ich schon viele gute Sachen entdeckt und deren Performance mit den Portfoliowerten lässt sich auch sehen.
Gruß Dr. Broemme
01.11.01 23:42
#15
flexo
Ich kann keine WL finden!?
Benutze sonst Yahoo dafür nicht- allerdings ist das wirklich umfangreich.